Skip to content

The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients

The Effects of Immersion in Dead Sea Water on Glucose Levels in Type 2 Diabetes Mellitus Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01580852
Enrollment
35
Registered
2012-04-19
Start date
2012-05-31
Completion date
2014-04-30
Last updated
2019-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Brief summary

BACKGROUND: Bathing in sweet or mineral water can induce significant physiological changes in several body systems including the endocrine system. To date, there have only been a small number of reports that balneology can reduce blood sugar Levels in patients with type 2 diabetes mellitus (DM\]. OBJECTIVE: To compare the effects of a immersion in sweet or mineral water on blood glucose levels in patients with type 2 DM. METHODS: Forty patients with type 2 DM will immerse in either sweet or mineral water twice daily. In both cases the water will be warmed to a temperature of 35 degrees C and the bath continue for 20 minutes.

Interventions

PROCEDUREDead Sea water

Subjects will immerse in mineral (dead sea) waters for twenty minutes twice daily for a period of 10 days

PROCEDUREPool water

Subjects will immerse in sweet(pool)waters for twenty minutes twice daily for a period of 10 days

Sponsors

Victor Novack
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Uncontrolled type 2 diabetes mellitus patients(HbA1c levels between 7.5-10) * Ages 18-65 * Signed Informed Consent

Exclusion criteria

* Peripheral neuropathy * Diabetic ulcers or damaged skin * PVD * Diabetes diagnosis for over 20 years * Orthostatic Hypotension

Design outcomes

Primary

MeasureTime frame
Glucose Levelsparticipants will be followed for the duration of hotel stay, an expected average of 5 days

Secondary

MeasureTime frame
HbA1c levelsthree months afer intervention

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026